Takeda Pharmaceutical Co Ltd  

(Public, TYO:4502)   Watch this stock  
Find more results for 4502
5,678.00
-67.00 (-1.17%)
Delayed:   12:45PM GMT+9
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 5,674.00 - 5,737.00
52 week 4,321.00 - 5,856.00
Open 5,729.00
Vol. 637,700.00
Mkt cap 4.49T
P/E 38.86
Div/yield 90.00/3.17
EPS 146.10
Shares 781.08M
Beta     -
Inst. own     -
Jul 28, 2017
Q1 2018 Takeda Pharmaceutical Co Ltd Earnings Call - 5:30PM GMT+9 - Add to calendar
Jul 28, 2017
Q1 2018 Takeda Pharmaceutical Co Ltd Earnings Call (Japanese) - 5:30PM GMT+9 - Add to calendar
Jul 28, 2017
Q1 2018 Takeda Pharmaceutical Co Ltd Earnings Release - 3:00PM GMT+9 - Add to calendar
Jun 29, 2017
Takeda Pharmaceutical Co Ltd Annual Shareholders Meeting (Estimated)
Jun 28, 2017
Takeda Pharmaceutical Co Ltd Annual Shareholders Meeting
Jun 26, 2017
Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd Announce ECHELON-1 Trial Results Conference Call
May 23, 2017
Takeda Pharmaceutical Co Ltd at UBS Global Healthcare Conference - Webcast
May 10, 2017
Full Year 2017 Takeda Pharmaceutical Co Ltd Earnings Presentation - Webcast
May 10, 2017
Full Year 2017 Takeda Pharmaceutical Co Ltd Earnings Presentation (Japanese)
May 10, 2017
Takeda Pharmaceutical Co Ltd at OBN's BioTrinity European Biopartnering and Investment Conference
  

Key stats and ratios

Q1 (Mar '17) 2017
Net profit margin -12.62% 6.67%
Operating margin -14.79% 8.69%
EBITD margin - 22.80%
Return on average assets -4.96% 2.82%
Return on average equity -10.50% 5.98%
Employees 29,900 -
CDP Score - A-

Address

4-1-1, Dosho-machi, Chuo-ku
OSAKA-SHI, OSK 540-8645
Japan
+81-6-62042111 (Phone)
+81-6-62042880 (Fax)

Website links

External links

Description

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. As of March 31, 2014, the Company had 146 subsidiaries and 17 associated companies.

Officers and directors

Yasuchika Hasegawa Chairman of the Board
Age: 71
Christophe Weber President, Chief Executive Officer, Representative Director
Age: 50
Shinji Honda President of Subsidiary, Corporate Strategy Office, Director
Age: 58
Andrew S. Plump Chief Medical & Scientific Officer, Director
Age: 51
Masato Iwasaki President of Japan Pharma Business Unit, Director
Age: 58
Yasuhiko Yamanaka Director
Age: 61
Emiko Azuma Independent Director
Age: 58
Jean-Luc Butel Independent Director
Age: 60
Yoshiaki Fujimori Independent Director
Age: 65
Koji Hatsukawa Independent Director
Age: 65